Insurance

The chief medical officer of Omada Health discusses a transition from one of the world's largest pharmaceutical companies to a digital health provider, and from treating chronic disease to preventing it.

CMS has issued an informal request for information seeking input on a new direction promoting patient-centered care and market-driven reforms for the CMS Innovation Center.

Truck drivers were identified in a Gallup survey as the profession most at risk for type 2 diabetes.

This study examined the early impacts of closing the donut hole in Medicare Part D.

Amanda Forys, MSPH, director of Xcenda’s Reimbursement Policy Insights consulting team, discusses how Medicare will address and possibly change its biosimilar policies as the FDA offers more guidance and as biosimilars become more prevalent in the market.

Just hours apart, 2 groups of senators unveiled health reform proposals that each take a drastically different approach to redefining the government’s role in healthcare.

A group that represents both community-based and virtual providers finds many issues with CMS' proposal for Medicare's Diabetes Prevention Program.

Geographic variation in healthcare spending and utilization within the Military Health System is higher and significantly correlated with Medicare across hospital referral regions.

Placing formulary restrictions on brand name drugs shifts use toward generics, lowers the cost per prescription fill, and has minimal impact on overall adherence for antidiabetes, antihyperlipidemia, and antihypertension medications among low-income subsidy recipients in Medicare Part D plans.

A Dexcom spokeswoman said there are already 20,000 Medicare patients in the pipeline with almost no advertisement of the policy change.

A new study indicates that palliative care can significantly reduce end-of-life hospitalizations and aggressive procedures among Medicare beneficiaries with advanced cancer.

To avoid bias, the study did use aggressive titration protocols that might be found in a real-world setting. Still, patients using CGM saw greater reductions in A1C and more time in range.

Study finds there is little evidence to suggest that an oxycodone HCI extended-release tablets nonformulary restriction has a direct effect on patient enrollment behavior.

This week, the top managed care articles included a report from the Congressional Budget Office on the impact of eliminating the cost-sharing reduction payments; a decision from CMS to eliminate 2 mandatory bundled payment programs; and a new value-based alliance that called for ending use of a test for diagnosing heart attacks.

Patrick Conway, MD, MSc, will leave his position as the deputy administrator for Innovation and Quality at CMS and the director of the Center for Medicare and Medicaid Innovation to lead Blue Cross and Blue Shield of North Carolina (Blue Cross NC).

Coverage from the 2017 meeting of the American Association of Diabetes Educators.

New research has found that the steady increase in the price of targeted oral anticancer medications is washing out the potential for savings that patients would experience in their out-of-pocket payments following closure of the Medicare Part D coverage gap.

Coverage from the 2017 meeting of the American Association of Diabetes Educators.

The standards warn that too few people with diabetes or prediabetes have access to programs that would help them.

Many accountable care organizations participating in the Medicare Shared Savings Program focus on disease control and medication use, but a new study published in JAMA Cardiology has found that the programs have not made any meaningful changes in medication use or adherence.